Rigel Pharmaceuticals | RIGL - 유동 자산





유동 자산 변화 날짜
Agenus USD 133.44M 514K 2025-12
Amgen USD 31.48B 2.42B 2026-03
Anika Therapeutics USD 93.56M 9.8M 2026-03
Arrowhead Research USD 1.17B 223.75M 2025-12
AstraZeneca USD 29.61B 890M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Celldex Therapeutics USD 534.66M 69.68M 2025-12
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Ligand Pharmaceuticals USD 832.27M 78.35M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Pfizer USD 42.82B 76M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Ultragenyx Pharmaceutical USD 951M 307.79M 2025-12
Veracyte USD 488.38M 39.15M 2025-12